Consistently with the in vitro findings, Western blotting and qRT-PCR analysis revealed that TP-0903 administration significantly downregulated the protein level (Fig. 6E) and mRNA expression (Fig. 6F) of DKK1 in the tumor derived from inoculated Neuro-2a cells (P < 0.01). Here, DKK1 is linked to neoplasm.